Viridamides A and B, lipodepsipeptides with antiprotozoal activity from the marine cyanobacterium Oscillatoria nigro-viridis

Journal of Natural Products

Volumn 71, Issue 9, 2008, Pages 1544-1550

  Simmons, T Luke ^a   Engene, Niclas ^a   Ureña, Luis David ^b   Romero, Luz I ^b   Ortega Barría, Eduardo ^b   Gerwick, Lena ^a   Gerwick, William H ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b Secretariat of Science and Technology   (Panama)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIPROTOZOAL AGENT; CHLOROQUINE; NIFURTIMOX; UNCLASSIFIED DRUG; VIRIDAMIDE A; VIRIDAMIDE B;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL REACTION; CONTROLLED STUDY; CYANOBACTERIUM; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC 50; NONHUMAN; NUCLEOTIDE SEQUENCE; OSCILLATORIA NIGRO VIRIDIS; PHYLOGENETIC TREE; PROTON NUCLEAR MAGNETIC RESONANCE;

ANIMALS; ANTIPROTOZOAL AGENTS; CYANOBACTERIA; DEPSIPEPTIDES; LEISHMANIA MEXICANA; MARINE BIOLOGY; MOLECULAR STRUCTURE; PANAMA; PLASMODIUM FALCIPARUM; TRYPANOSOMA CRUZI;

BLENNOTHRIX; CYANOBACTERIA; OSCILLATORIA NIGRO-VIRIDIS; TRICHODESMIUM;

EID: 54149116264     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np800110e     Document Type: Article

References (45)

1. http://www.who.int/neglected_diseases/en/.
2. Trouiller, P.; Olliara, P.; Torreele, E.; Orbinski, J.; Laing, R.; Ford, N. Lancet 2002, 359, 2188-2194.
3. Yamey, G. Br. J. Med. 2002, 325, 176-177.
4. Teixeira, A. R. L.; Nascimento, R. J.; Sturm, N. R. Mem. Inst. Oswaldo Cruz 2006, 101, 463-491.
5. www.who.int/leishmaniasis/en/.
6. Guerin, P. J.; Olliaro, P.; Sundar, S.; Boelaert, M.; Croft, S. L.; Desjeux, P.; Wasunna, M. K.; Bryceson, A. D. M. Lancet Infect. Dis. 2002, 2, 494-501.
7. World Health Organization. Control of Chagas Disease, second report of the WHO expert committee; Technical Report Series, Vol. 905, WHO: Geneva, 2002.
8. Sanderson, L.; Khan, A.; Thomas, S. Antimicrob. Agents Chemother. 2007, 51, 3136-3146.
9. (a) Lee, J.; Michael, A. J.; Martynowski, D.; Goldsmith, E. J.; Phillips, M. A. J. Biol. Chem. 2007, 282, 27115-27125.
10. (b) Priotto, G.; Kasparian, S.; Nqouama, D.; Ghorashian, S.; Arnold, U.; Ghabri, S.; Karunakara, U. Clin. Infect. Dis. 2007, 45, 1435-1442.
11. Carrillo, C.; González, N. S.; Algranati, I. D. Biochim. Biophys. Acta 2007, 1770, 1605-1611.
12. Bouteille, B.; Oukem, O.; Bisser, S.; Dumas, M. Fundam. Clin. Pharmacol. 2003, 17, 171-181.
13. Seifert, K.; Lemke, A.; Croft, S. L.; Kayser, O. Antimicrob. Agents Chemother. 2007, 51, 4525-4528.
14. (a) Sanchez, L. A.; Capitan, Z.; Romero, L. I.; Ortega-Barria, E.; Gerwick, W. H.; Cubilla-Rios, L. Nat. Prod. Commun. 2007, 2, 1065-1069.
15. (b) McPhail, K. L.; Correa, J.; Linington, R. G.; Gonzalez, J.; Ortega-Barria, E.; Capson, T. L.; Gerwick, W. H. J. Nat. Prod. 2007, 70, 984-988.
16. Gerwick, W. H.; Tan, L.; Sitachitta, N. The Alkaloids; Academic Press: San Diego, 2001; Vol. 57, pp 75-184.
17. (a) Marquardt, J.; Palinska, K. A. Arch. Microbiol. 2007, 187, 5, 397-413.
18. (b) Rajaniemi, P.; Hrouzek, P.; Katovská, K.; Willame, R.; Rantala, A.; Hoffmann, L.; Komárek, J.; Sivonen, K. Int. J. Syst. Evol. Microbiol. 2005, 55, 11-26.
19. (c) Clark, B. R.; Engene, N.; Gerwick, W. H. J. Nat.Prod. 2008,submitted.
20. 3OH (2:1) followed by normal-phase vacuum liquid chromatography using an organic mobile phase of increasing polarity generating nine fractions (A-I).
21. These fractions were initially active in a cell toxicity screen, but the activity did not repeat.
22. (a) FujIV, K.; Ikau, Y.; Oka, H.; Suzuki, M.; Harada, K. Anal. Chem. 1997, 69, 3346-3352.
23. (b) FujIV, K.; Ikau, Y.; Oka, H.; Suzuki, M.; Harada, K. Anal. Chem. 1997, 69, 5146-5151.
24. (c) Marfey, P. Calsberg Res. Commun. 1984, 49, 591-596.
25. Mamer, O. A. Methods Enzymol. 2000, 324, 3-10.
26. Linington, R. G.; Gonzalez, J.; Ureña, L. D.; Romero, L. I.; Ortega-Barría, E.; Gerwick, W. H. J. Nat. Prod. 2007, 70, 397-401.
27. (a) Geitler, L. Akad. Verlagsgesellschaft 1932, 942-943.
28. (b) Komárek, J.; Anagnostidis, K. Süsswasserflora Mitteleuropa 2005, 19/2, 576-579.
29. Castenholz, R. W.; Rippka, R.; Herdman, M. Bergey's Manual Syst. Bacteriol. 2001, 1, 492-553.
30. Abed, R. M.; Palinska, K. A.; Camoin, G.; Gulobic, S. FEMS Microbiol. Lett. 2006, 260, 171-177.
31. Sudek, S.; Haygood, M. G.; Youssef, D. T. A.; Schmidt, E. W. Appl. Environ. Microbiol. 2006, 72, 4382-4387.
32. Van Wagoner, R.; Drummond, A. K.; Wright, J. L. C. Adv. Appl. Microbiol. 2007, 61, 89-217.
33. Katirciogľu, H.; Akin, B. S.; Tahir, A. Afr. J. Biotech. 2004, 3, 667-674.
34. Wilkinson, C. R.; Sammarco, P. W. Mar. Ecol.: Prog. Ser. 1983, 13, 15-19.
35. (a) Mynderse, J. S.; Moore, R. E.; Kashiwagi, M.; Norton, T. R. Science 1977, 196, 538-540.
36. (b) Mynderse, J. S.; Moore, R. E. J. Org. Chem. 1978, 43, 2301-2303.
37. Hooper, G. J.; Orjala, J.; Schatzman, R. C.; Gerwick, W. H. J. Nat. Prod. 1998, 61, 529-533.
38. Edwards, D. J.; Marquez, B. L.; Nogle, J. N.; McPhail, K.; Goeger, D. E.; Roberts, M. A.; Gerwick, W. H. Chem. Biol. 2004, 11, 817-833.
39. Leusch, H.; Yoshida, W. Y.; Moore, R. E.; Paul, V. J. J. Nat. Prod. 2000, 63, 1106-1112.
40. (a) Gerwick, W. H.; Roberts, M. A.; Proteau, P. J.; Chen, J.-L. J. Appl. Phycol. 1994, 6, 143-149.
41. (b) Nubel, U.; Garcia-Pichel, F.; Muyzer, G. Appl. Environ. Microbiol. 1997, 63, 3327-3332.
42. Buckner, F. S.; Verlinde, C. L.; LaFlamme, A. C.; Van Boris, W. C. Antimicrob. Agents Chemother. 1996, 40, 2592-2597.
43. Gutierrez, M.; Capson, T. L.; Guzman, H. M.; Gonzalez, J.; Ortega-Barria, E.; Quinoa, E.; Riguera, R. J. Nat. Prod. 2006, 69, 1379-1383.
44. Calderon, A.; Romero, L.; Oretga-Barria, E.; Brun, R.; Correa, M.; Gupta, M. P. Panama Pharm. Biol. 2006, 44, 1-16.
45. Kumar, S.; Tamura, K.; Nei, M. Briefings Bioinf. 2004, 5, 150-163.